FDA grants South Texas Blood & Tissue Center first license for new process that triples shelf life of critically needed platelets

FDA grants South Texas Blood & Tissue Center first license for new process that triples shelf life of critically needed platelets

Breakthrough expected to increase availability of platelets for treating cancer patients and active bleeding cases

Click to Read More